title: Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
abstract: During a T cell response, the effector CTL pool contains two cellular subsets: short-lived effector cells (SLECs), a majority of which are destined for apoptosis, and the memory precursor effector cells, which differentiate into memory cells. Understanding the mechanisms that govern the differentiation of memory CD8 T cells is of fundamental importance in the development of effective CD8 T cell-based vaccines. The strength and nature of TCR signaling, along with signals delivered by cytokines like IL-2 and IL-12, influence differentiation of SLECs and memory precursor effector cells. A central question is, how are signals emanating from multiple receptors integrated and interpreted to define the fate of effector CTLs? Using genetic and pharmacological tools, we have identified Akt as a signal integrator that links distinct facets of CTL differentiation to the specific signaling pathways of FOXO, mTOR, and Wnt/β-catenin. Sustained Akt activation triggered by convergent extracellular signals evokes a transcription program that enhances effector functions, drives differentiation of terminal effectors, and diminishes the CTLs' potential to survive and differentiate into memory cells. Whereas sustained Akt activation severely impaired CD8 T cell memory and protective immunity, in vivo inhibition of Akt rescued SLECs from deletion and increased the number of memory CD8 T cells. Thus, the cumulative strength of convergent signals from signaling molecules such as TCR, costimulatory molecules, and cytokine receptors governs the magnitude of Akt activation, which in turn controls the generation of long-lived memory cells. These findings suggest that therapeutic modulation of Akt might be a strategy to augment vaccine-induced immunity.
authors.affiliation: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
authors.forename: Eui Ho
authors.initials: EH
authors.lastname: Kim
authors.forename: Jeremy A
authors.initials: JA
authors.lastname: Sullivan
authors.forename: Erin H
authors.initials: EH
authors.lastname: Plisch
authors.forename: Melba Marie
authors.initials: MM
authors.lastname: Tejera
authors.forename: Anna
authors.initials: A
authors.lastname: Jatzek
authors.forename: Kwan Yong
authors.initials: KY
authors.lastname: Choi
authors.forename: M
authors.initials: M
authors.lastname: Suresh
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000201:enzymology / Q000276:immunology*; D002454:Cell Differentiation / Q000502:physiology*; D004789:Enzyme Activation / Q000276:immunology; D051858:Forkhead Transcription Factors / Q000276:immunology / Q000378:metabolism; D007156:Immunologic Memory / Q000502:physiology*; D018664:Interleukin-12 / Q000276:immunology / Q000378:metabolism; D007376:Interleukin-2 / Q000276:immunology / Q000378:metabolism; D051379:Mice; D051057:Proto-Oncogene Proteins c-akt / Q000276:immunology* / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000276:immunology / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000276:immunology / Q000378:metabolism; D051153:Wnt Proteins / Q000276:immunology / Q000378:metabolism; D051176:beta Catenin / Q000276:immunology / Q000378:metabolism
chemical_list: D051858:Forkhead Transcription Factors; D007376:Interleukin-2; D011948:Receptors, Antigen, T-Cell; D051153:Wnt Proteins; D051176:beta Catenin; D018664:Interleukin-12; C546843:mTOR protein, mouse; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases